North America Topical Scar Treatment Market Size, Share & Trends Analysis Report By End-use, By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks), By Product, By Country and Growth Forecast, 2023 - 2030
The North America Topical Scar Treatment Market would witness market growth of 8.6% CAGR during the forecast period (2023-2030).
The US market dominated the North America Topical Scar Treatment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $7,232.4 million by 2030. The Canada market is experiencing a CAGR of 11% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10% during (2023 - 2030).
As consumers become more informed about skincare and the availability of scar treatment options, the demand for topical solutions may rise. Preferences for non-invasive and easily applicable treatments may boost the adoption of topical scar treatments. Products that offer convenience and minimal side effects are more popular. These are often recommended for managing scars resulting from surgical procedures.
Scars resulting from accidents, injuries, or trauma can be treated with topical products to minimize their appearance. This is especially important for scars on the face or other visible areas. These may improve the texture and colour of scars caused by burns. These products aim to hydrate the skin, promote collagen production and reduce inflammation. Individuals with acne scars often use topical treatments to address both hyperpigmentation and textural irregularities.
As per the International Trade Administration (ITA), in the first half of 2022, the Canadian cosmetics industry was the fastest-growing industry in the country. In 2022, Canada’s personal care and beauty sector earned around $11 billion in revenue. Canada has witnessed a growing demand for cosmetic procedures, including surgical and non-surgical interventions. Non-invasive cosmetic procedures, such as laser treatments, microdermabrasion, and injectables, have become increasingly popular in Canada. Hence, the factors mentioned above will drive the regional market growth.
Based on End-use, the market is segmented into Hospitals, Clinics, and Homecare. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on Product, the market is segmented into Creams, Gels, Silicon Sheets, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
By End-use
- Hospitals
- Clinics
- Homecare
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
- Creams
- Gels
- Silicon Sheets
- Others
- US
- Canada
- Mexico
- Rest of North America
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Topical Scar Treatment Market, by End-use
- 1.4.2 North America Topical Scar Treatment Market, by Scar Type
- 1.4.3 North America Topical Scar Treatment Market, by Product
- 1.4.4 North America Topical Scar Treatment Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
- 3.3 Porter’s Five Forces Analysis
- Chapter 4. North America Topical Scar Treatment Market by End-use
- 4.1 North America Hospitals Market by Country
- 4.2 North America Clinics Market by Country
- 4.3 North America Homecare Market by Country
- Chapter 5. North America Topical Scar Treatment Market by Scar Type
- 5.1 North America Atrophic Scars Market by Country
- 5.2 North America Hypertrophic & Keloid Scars Market by Country
- 5.3 North America Contracture Scars Market by Country
- 5.4 North America Stretch Marks Market by Country
- Chapter 6. North America Topical Scar Treatment Market by Product
- 6.1 North America Creams Market by Country
- 6.2 North America Gels Market by Country
- 6.3 North America Silicon Sheets Market by Country
- 6.4 North America Others Market by Country
- Chapter 7. North America Topical Scar Treatment Market by Country
- 7.1 US Topical Scar Treatment Market
- 7.1.1 US Topical Scar Treatment Market by End-use
- 7.1.2 US Topical Scar Treatment Market by Scar Type
- 7.1.3 US Topical Scar Treatment Market by Product
- 7.2 Canada Topical Scar Treatment Market
- 7.2.1 Canada Topical Scar Treatment Market by End-use
- 7.2.2 Canada Topical Scar Treatment Market by Scar Type
- 7.2.3 Canada Topical Scar Treatment Market by Product
- 7.3 Mexico Topical Scar Treatment Market
- 7.3.1 Mexico Topical Scar Treatment Market by End-use
- 7.3.2 Mexico Topical Scar Treatment Market by Scar Type
- 7.3.3 Mexico Topical Scar Treatment Market by Product
- 7.4 Rest of North America Topical Scar Treatment Market
- 7.4.1 Rest of North America Topical Scar Treatment Market by End-use
- 7.4.2 Rest of North America Topical Scar Treatment Market by Scar Type
- 7.4.3 Rest of North America Topical Scar Treatment Market by Product
- Chapter 8. Company Profiles
- 8.1 Smith & Nephew PLC
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional and Segmental Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
- 8.2 Lumenis Be Ltd.
- 8.2.1 Company Overview
- 8.2.2 Recent strategies and developments:
- 8.2.2.1 Partnerships, Collaborations, and Agreements:
- 8.2.2.2 Product Launches and Product Expansions:
- 8.2.3 SWOT Analysis
- 8.3 Merz Pharma GmbH & Co. KGaA
- 8.3.1 Company Overview
- 8.3.2 Recent strategies and developments:
- 8.3.2.1 Partnerships, Collaborations, and Agreements:
- 8.3.3 SWOT Analysis
- 8.4 Sonoma Pharmaceuticals, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
- 8.4.5.1 Product Launches and Product Expansions:
- 8.4.6 SWOT Analysis
- 8.5 Molnlycke Health Care AB
- 8.5.1 Company Overview
- 8.5.2 SWOT Analysis
- 8.6 Suneva Medical, Inc.
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
- 8.6.2.1 Product Launches and Product Expansions:
- 8.6.3 SWOT Analysis
- 8.7 Perrigo Company PLC
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
- 8.8 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- 8.8.1 Company Overview
- 8.8.2 Recent strategies and developments:
- 8.8.2.1 Partnerships, Collaborations, and Agreements:
- 8.8.2.2 Product Launches and Product Expansions:
- 8.8.3 SWOT Analysis
- 8.9 Newmedical Technology Inc.
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
- 8.10. Integra LifeSciences Holdings Corporation
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Segmental and Regional Analysis
- 8.10.4 Research & Development Expenses
- 8.10.5 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook